Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Randomized clinical trial assessing the safety and immunogenicity of oral microencapsulated enterotoxigenic Escherichia coli surface antigen 6 with or without heat-labile enterotoxin with mutation R192G.

Lapa JA, Sincock SA, Ananthakrishnan M, Porter CK, Cassels FJ, Brinkley C, Hall ER, van Hamont J, Gramling JD, Carpenter CM, Baqar S, Tribble DR.

Clin Vaccine Immunol. 2008 Aug;15(8):1222-8. doi: 10.1128/CVI.00491-07. Epub 2008 Jun 25.

2.

Mucosal and systemic immune responses in patients with diarrhea due to CS6-expressing enterotoxigenic Escherichia coli.

Qadri F, Ahmed T, Ahmed F, Bhuiyan MS, Mostofa MG, Cassels FJ, Helander A, Svennerholm AM.

Infect Immun. 2007 May;75(5):2269-74. Epub 2007 Feb 12.

3.

Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli.

Coster TS, Wolf MK, Hall ER, Cassels FJ, Taylor DN, Liu CT, Trespalacios FC, DeLorimier A, Angleberger DR, McQueen CE.

Infect Immun. 2007 Jan;75(1):252-9. Epub 2006 Oct 30.

6.

Comparative safety and immunogenicity of two attenuated enterotoxigenic Escherichia coli vaccine strains in healthy adults.

McKenzie R, Bourgeois AL, Engstrom F, Hall E, Chang HS, Gomes JG, Kyle JL, Cassels F, Turner AK, Randall R, Darsley M, Lee C, Bedford P, Shimko J, Sack DA.

Infect Immun. 2006 Feb;74(2):994-1000.

7.

The New World primate, Aotus nancymae, as a model for examining the immunogenicity of a prototype enterotoxigenic Escherichia coli subunit vaccine.

Jones FR, Hall ER, Tribble D, Savarino SJ, Cassels FJ, Porter C, Meza R, Nunez G, Espinoza N, Salazar M, Luckett R, Scott D.

Vaccine. 2006 May 1;24(18):3786-92. Epub 2005 Aug 30.

PMID:
16343702
9.

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers.

Carpenter CM, Hall ER, Randall R, McKenzie R, Cassels F, Diaz N, Thomas N, Bedford P, Darsley M, Gewert C, Howard C, Sack RB, Sack DA, Chang HS, Gomes G, Bourgeois AL.

Vaccine. 2006 May 1;24(18):3709-18. Epub 2005 Jul 26.

PMID:
16153753
10.

Microencapsulated subunit vaccine approach to enterotoxigenic Escherichia coli and other mucosal pathogens.

Byrd W, de Lorimier A, Zheng ZR, Cassels FJ.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1362-80. Epub 2005 Apr 26. Review.

PMID:
15935878
12.

Evolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli.

Anantha RP, McVeigh AL, Lee LH, Agnew MK, Cassels FJ, Scott DA, Whittam TS, Savarino SJ.

Infect Immun. 2004 Dec;72(12):7190-201.

13.

Murine antibody response to intranasally administered enterotoxigenic Escherichia coli colonization factor CS6.

de Lorimier AJ, Byrd W, Hall ER, Vaughan WM, Tang D, Roberts ZJ, McQueen CE, Cassels FJ.

Vaccine. 2003 Jun 2;21(19-20):2548-55.

PMID:
12744890
15.

Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen.

Katz DE, DeLorimier AJ, Wolf MK, Hall ER, Cassels FJ, van Hamont JE, Newcomer RL, Davachi MA, Taylor DN, McQueen CE.

Vaccine. 2003 Jan 17;21(5-6):341-6.

PMID:
12531630
17.

Recruitment of murine neutrophils in vivo through endogenous sialidase activity.

Cross AS, Sakarya S, Rifat S, Held TK, Drysdale BE, Grange PA, Cassels FJ, Wang LX, Stamatos N, Farese A, Casey D, Powell J, Bhattacharjee AK, Kleinberg M, Goldblum SE.

J Biol Chem. 2003 Feb 7;278(6):4112-20. Epub 2002 Nov 22.

18.

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Güereña-Burgueño F, Hall ER, Taylor DN, Cassels FJ, Scott DA, Wolf MK, Roberts ZJ, Nesterova GV, Alving CR, Glenn GM.

Infect Immun. 2002 Apr;70(4):1874-80.

19.

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.

Yu J, Cassels F, Scharton-Kersten T, Hammond SA, Hartman A, Angov E, Corthésy B, Alving C, Glenn G.

Infect Immun. 2002 Mar;70(3):1056-68.

21.

Structural characterization of the Pseudomonas aeruginosa 1244 pilin glycan.

Castric P, Cassels FJ, Carlson RW.

J Biol Chem. 2001 Jul 13;276(28):26479-85. Epub 2001 May 7.

22.
23.

Characterization of an enterotoxigenic Escherichia coli strain from Africa expressing a putative colonization factor.

Khalil SB, Cassels FJ, Shaheen HI, Pannell LK, El-Ghorab N, Kamal K, Mansour M, Savarino SJ, Peruski LF Jr.

Infect Immun. 1999 Aug;67(8):4019-26.

24.

Linear epitopes of colonization factor antigen I and peptide vaccine approach to enterotoxigenic Escherichia coli.

Cassels FJ, Jarboe DL, Reid RH, Lees A, Deal CD.

J Ind Microbiol Biotechnol. 1997 Jul;19(1):66-70.

PMID:
9281854
25.

Peptide epitope mapping in vaccine development: introduction.

Castric PA, Cassels FJ.

J Ind Microbiol Biotechnol. 1997 Jul;19(1):56-7.

PMID:
9281852
26.

The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunits.

Wolf MK, de Haan LA, Cassels FJ, Willshaw GA, Warren R, Boedeker EC, Gaastra W.

FEMS Microbiol Lett. 1997 Mar 1;148(1):35-42.

27.

Colonization factors of diarrheagenic E. coli and their intestinal receptors.

Cassels FJ, Wolf MK.

J Ind Microbiol. 1995 Sep;15(3):214-26. Review.

PMID:
8519480
28.

Adhesin receptors of human oral bacteria and modeling of putative adhesin-binding domains.

Cassels FJ, Hughes CV, Nauss JL.

J Ind Microbiol. 1995 Sep;15(3):176-85. Review.

PMID:
8519475
29.

Isolation and structural characterization of adhesin polysaccharide receptors.

Cassels FJ, van Halbeek H.

Methods Enzymol. 1995;253:69-91. Review.

PMID:
7476419
30.

Hemolymph lectins of the blue crab, Callinectes sapidus, recognize selected serotypes of its pathogen Vibrio parahaemolyticus.

Cassels FJ, Odom EW, Vasta GR.

Ann N Y Acad Sci. 1994 Apr 15;712:324-6. No abstract available.

PMID:
8192339
31.

Coaggregation: specific adherence among human oral plaque bacteria.

Kolenbrander PE, Ganeshkumar N, Cassels FJ, Hughes CV.

FASEB J. 1993 Mar;7(5):406-13. Review.

PMID:
8462782
32.

Complete structure of the adhesin receptor polysaccharide of Streptococcus oralis ATCC 55229 (Streptococcus sanguis H1).

Glushka J, Cassels FJ, Carlson RW, van Halbeek H.

Biochemistry. 1992 Nov 10;31(44):10741-6.

PMID:
1420190
33.
35.

Structure of a streptococcal adhesin carbohydrate receptor.

Cassels FJ, Fales HM, London J, Carlson RW, van Halbeek H.

J Biol Chem. 1990 Aug 25;265(24):14127-35.

36.
37.
38.

Supplemental Content

Loading ...
Support Center